According to io9, a seventy-nine-year-old patient received special access to an experimental weight-loss drug. The White House denied that the application was filed on behalf of President Donald Trump. The identity of the actual patient has not been disclosed, raising questions about the process for granting special access to experimental medications and whether certain individuals receive preferential treatment.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton